Clinical Innovation Program – Spread of Innovation


The aim of the ACI Clinical Innovation Program is to:

  1. Accelerate implementation of ACI Models of Care and Guidelines; 
  2. Assist in the sharing and spread of local innovations.


  • Improved implementation and system uptake of models, with demonstrated patient and health system benefit; 
  • Reduction in time and effort for LHDs to replicate contemporary evidence based models; 
  • Opportunities for LHDs to receive funding to implement the model.


The Clinical Innovation Program consists of two streams:

  1. The ACI will invest up to $1m on a variety of methods and opportunities to assist LHDs and SHNs to accelerate implementation of ACI Models of Care and Guidelines.
  2. The ACI will invest up to a further $1m to enhance the spread of innovation across the NSW Health system. This will be accomplished by conducting a review of the NSW Health Innovation Award Finalists, and projects from the Centre for Healthcare Redesign school to determine which initiatives have potential for replication at a state level. These initiatives are prioritised by a steering committee with membership representation from a facility, LHD, Network and system level perspective. The sustainability of these prioritised initiatives is confirmed before due diligence is performed to independently evaluate the initiative. This initiative is shared with relevant ACI Networks to ensure that it is contemporary and evidence based before it is compared to other similar programs from around the state. Where other programs are seen to enhance the identified initiative, these wll be built into the documented innovation. This innovation will be shared with the system, with the opportunity for some LHDs to pilot this innovation with ACI support.


Innovation is about finding a better way of doing something. It can be defined as “the intentional introduction and application within a role, group, or organisation, of ideas, processes, products or procedures, new to the relevant unit of adoption, designed to significantly benefit the individual, the group, or wider society”1.

Given the multiple levels of innovation required for sustainable improvements in a system such as NSW Health, the ACI has recognised the importance of the Innovation Cycle comprised of five stages:

  • Innovation – organisational horizon scanning to learn of new and emerging ideas being developed at the coalface
  • Evaluation – assessing quality, safety, efficacy and cost benefit of the innovation
  • Adoption – active adoption of an innovation involves consideration of a range of issues such as: is this a problem in this health service; the impact on the health system, the effectiveness in a local environment and initial and recurrent funding requirements to implement and sustain the innovation
  • Optimisation – optimising the use of an innovation requires:  agreed outcome measure and evaluation processes, resources for data collection and analysis, a mechanism for feedback to both the frontline and management as well as systems to support continuous improvement
  • Disinvestment – involves an active decision to cease to do something as it has been replaced or superseded by the innovation. In a system with limited resources, disinvestment contributes to the success of innovation.

1 West, M.A. 1990. The Social Psychology of Innovation in Groups. In M.A. West and J.L Farr (Eds.), Innovation and Creativity at Work: Psychological and Organizational Strategies Chichester, UK: Wiley, pp. 309-334.


Partnerships will be established with Local Health Districts, Specialty Health Networks, Medicare Locals and Pillars where an initiative specifically relates to them.

  • South Western Sydney Local Health District
  • South Eastern Sydney Local Health District

Key Dates

This program will run continuously through the year.

Key innovations for Stream 2 – Spread of Local Innovation will be identified following the NSW Health Innovation Awards.

Pilot Sites

Implementation Sites


Both Streams of the Clinical Innovation Program will be evaluated independently.

Related Initiatives

Further Details


Chris Ball
Implementation Manager
02 9464 4656

Raj Verma
Director, Clinical Program Design and Implementation
02 9464 4605

Page Top | Added: 4 August 2014 | Last modified: 7 August 2014

Chris Ball
Implementation Manager
02 9464 4656